Most Read Articles
6 days ago
Chronic pancreatitis patients taking antioxidants (AO) supplementation show a sustained increase in blood levels of AO, but no additional benefit is seen on endocrine and exocrine functions, markers of fibrosis, oxidative stress (OS) and inflammation, nutritional status, pain, and quality of life (QOL) when compared with those on placebo, according to a study.
29 Nov 2019
Metformin Extended Release 500 mg,750 mg, and 1000 mg
01 Dec 2019
Pneumonia is a common infection– affecting around 3,200 people inSingapore in 2016 – making it the thirdmost common cause of hospitalisation inthe country. Its common complications,especially with delayed or inappropriatetreatment, include bacteraemia andseptic shock, lung abscesses, pleuraleffusions, empyema, pleurisy, respiratoryfailure and renal failure.
Stephen Padilla, 13 Feb 2020
A pharmacist intervention appears to be effective in lowering and preventing the incidence of prescribing errors of investigational drugs in oncology clinical trials, a recent study has shown.

Sesame oil improves cardiometabolic risk factors in patients with metabolic syndrome

05 Nov 2019
Used cooking oil must be stored properly for safe re-use.

Sesame oil with or without vitamin E improves several cardiometabolic indices, including lipids, fasting blood glucose (FBG), blood pressure (BP), homeostatic model assessment (HOMA-IR) and malondialdehyde among others, in patients with metabolic syndrome (MetS), results of a randomized, single-blind controlled trial have shown.

This study sought to examine the effects of sesame oil enriched with vitamin E, sesame oil alone and sunflower oil on lipid profile, FBG, malondialdehyde, high-sensitivity C-reactive protein (hs-CRP), HOMA-IR and BP in patients with MetS.

Seventy-five individuals with MetS aged 30–70 years were randomly assigned to sesame oil 30 ml/day enriched with vitamin E 400 mg/day (group A, n=25), sesame oil alone (group B, n=25) or sunflower oil 30 ml/day (group C, n=25). The authors measured anthropometric data, dietary intake, BP and biochemical markers, including fasting serum lipids, FBG, serum insulin, malondialdehyde and hs-CRP at baseline and at week 8.

Participants in group A had significant reductions in serum total cholesterol (TC), triglycerides, FBG, HOMA-IR, malondialdehyde, hs-CRP, high-density lipoprotein cholesterol (HDL-C), and systolic and diastolic BP (p-all<0.02). Group B participants also significantly improved TC, triglycerides, HOMA-IR, malondialdehyde, and systolic and diastolic BP (p-all<0.025), but no significant changes were seen in serum HDL (35.9±7.2 vs 36.4±6.2 mg/dL; p=0.432) and hs-CRP (4.38±1.34 vs 3.96±1.7 mg/dL; p=0.057).

There were no significant changes in any of the clinical and anthropometric data in group C.

“MetS represents a clustering of metabolic abnormalities that are associated with an increased risk of type 2 diabetes and cardiovascular disease,” the authors noted.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago
Chronic pancreatitis patients taking antioxidants (AO) supplementation show a sustained increase in blood levels of AO, but no additional benefit is seen on endocrine and exocrine functions, markers of fibrosis, oxidative stress (OS) and inflammation, nutritional status, pain, and quality of life (QOL) when compared with those on placebo, according to a study.
29 Nov 2019
Metformin Extended Release 500 mg,750 mg, and 1000 mg
01 Dec 2019
Pneumonia is a common infection– affecting around 3,200 people inSingapore in 2016 – making it the thirdmost common cause of hospitalisation inthe country. Its common complications,especially with delayed or inappropriatetreatment, include bacteraemia andseptic shock, lung abscesses, pleuraleffusions, empyema, pleurisy, respiratoryfailure and renal failure.
Stephen Padilla, 13 Feb 2020
A pharmacist intervention appears to be effective in lowering and preventing the incidence of prescribing errors of investigational drugs in oncology clinical trials, a recent study has shown.